Empagliflozin attenuates doxorubicin-induced cardiotoxicity by activating AMPK/SIRT-1/PGC-1α-mediated mitochondrial biogenesis.
- Published in:
- Toxicology Research, 2023, v. 12, n. 2, p. 216, doi. 10.1093/toxres/tfad007
- By:
- Publication type:
- Article
Works by Chen, Meicong
Results: 1
1